MeMed, a leader in advanced host-response diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to MeMed BV Flextm, a test ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

Could weight-loss medications such as Ozempic and Wegovy offer benefits beyond weight reduction? Recent research indicates that these GLP-1 therapies might provide heart protection following a heart ...

Understanding how aging reshapes the body and why physical function often declines over time has become a central focus of modern biomedical research. A new Yale School of Medicine (YSM) study, ...

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

Using rodent and cellular models, the researchers showed that tanycytes take up tau from the CSF and release it into ...

—Breakthrough Device Designation to streamline regulatory review and support a pathway toward broader reimbursement coverage— ANDOVER, Mass. and HAIFA, Israel, March 11, 2026 /PRNewswire/ — MeMed, a ...

New concepts in device therapy for advanced heart failure presented in early reports ...

Researchers developed super-resolution functional photoacoustic microscopy to track single red blood cells in mouse brains, advancing study of cerebral small vessel disease.

While massage guns are generally safe when used correctly, improper use or existing medical conditions can lead to side effects, ranging from mild discomfort to rare but serious injuries.

The company's BV Flex test measures patient immune proteins in capillary blood samples to determine whether an individual has a bacterial or viral infection.